Skip to content

Clinical trials

Lennox Gastaut Syndrome trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lennox Gastaut Syndrome Country / region: Australia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20161
20171
20182
20191
20211
20224
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Recruiting2
Active, not recruiting1
Available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Longboard Pharmaceuticals5
Takeda4
Bright Minds Biosciences Pty Ltd1
Eisai Inc.1
Lundbeck LLC1
SK Life Science, Inc.1
University of California, San Francisco1
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.1
Zogenix, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lennox Gastaut Syndrome16
Epilepsies, Myoclonic9
Epilepsy9
Seizures5
Tuberous Sclerosis4
Malformations of Cortical Development2
Neurodevelopmental Disorders2
Spasms, Infantile2
Brain Diseases1
Central Nervous System Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.